NIGP 19394: Urinalysis Reagents and Tests (for Albumin, Bile, Blood, Glucose, Ketones, etc.)

NIGP Item 19394 Urinalysis Reagents and Tests covers diagnostic laboratory testing services—including urinalysis screening, multi-panel drug testing, immunoassay analysis with confirmation methods, and related specimen collection and result reporting—that state and local health and criminal justice agencies procure to support offender supervision, clinical diagnostics, and population health screening. State and local issuers soliciting under this code include county community supervision and corrections departments, county health services divisions, and specialized mental health and intellectual/developmental disability (IDD) agencies. The work encompasses full-service laboratory operations with reagent supply, staffing, equipment provision, and electronic result reporting integrated into existing health information systems, rather than reagent-only commodity procurement.

Recent activity concentrates in Texas, where Collin County Community Supervision and Corrections Department posted RFP 2026-327 for offender specimen collection and drug testing services (approximately 25,031 annual tests, five- and six-panel screens with LC/MS/MS or GC/MS confirmation, $600,000 estimated value, proposals due July 23, 2026), Collin County Health Care Services posted IFB 2025-166 for comprehensive laboratory services across 200+ test types including urinalysis (approximately 217 annual tests, $70,000 estimated annual value, bid deadline October 2, 2025), and Harris Center for Mental Health and IDD posted RFP FY260273 for agency-wide clinical laboratory services spanning urinalysis with microscopy and drug screening across multiple Houston-area locations (approximately 2,200 monthly tests, responses due June 17, 2026). All three solicitations require SAMHSA, CAP, CLIA, or equivalent laboratory certification; electronic result reporting via EHR integration; and supplier responsibility for equipment, materials, and staffing at contracted per-test rates. The Harris Center's RFP weights EHR interface capability (30 percent) and laboratory test delivery capability (20 percent) most heavily, signaling increasing buyer emphasis on integration and operational capacity over price alone.